New era of personalized medicine: Advanced therapy medicinal products in Europe

doi:10.5411/wji.v11.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8208)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-1) series.

Item

Count

PDF

309

WORD

230

HTML

4393

Tables (1-1)

369

Sum=5301

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

477

Download

1303

Sum=1780

Publishing Process of This Article

Item

Count

Browse

415

Download

712

Sum=1127

Jul 24, 2021 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Immunology

ISSN

2219-2824

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Immunol. Jul 24, 2021; 11(1): 1-10
Published online Jul 24, 2021. doi: 10.5411/wji.v11.i1.1

Table 1 Summary of different advanced therapy medicinal products approved by the European Medicines Agency with their approval date and withdrawal date, if applicable

Advanced therapy medicinal products
Gene therapies	EC approval	Withdrawal	Cell therapies	EC approval	Withdrawal	Tissue-based therapies	EC approval	Withdrawal
Glybera	Oct-12	Oct-17	Provenge	Sept-13	May-15	MACI	Jun-13	Sept-14
Imlygic	Dec-15		Zalmoxis	Aug-16	Feb-20	Holoclar	Feb-15
Strimvelis	May-16		Alofisel	Mar-18		Spherox	Jul-17
Kymriah	Sept-18		Chondrocelect	Oct-09	Jan-17
Yescarta	Sept-18
Luxturna	Nov-18
Zynteglo	Jun-19
Zolgensma	Mar-20

EC: European Commission.

Citation: García-González J, Marhuenda-Castillo S, Romero-Carretero S, Beltrán-García J. New era of personalized medicine: Advanced therapy medicinal products in Europe. World J Immunol 2021; 11(1): 1-10
URL: https://www.wjgnet.com/2219-2824/full/v11/i1/1.htm
DOI: https://dx.doi.org/10.5411/wji.v11.i1.1